The transactions highlight Broadwood Partners' continued confidence in STAAR Surgical (NASDAQ:STAA), a company known for its ...

Stifel Nicolaus analyst Thomas Stephan has maintained their bullish stance on STAA stock, giving a Buy rating on January 7.Stay Ahead of the ...

On January 17, BROADWOOD PARTNERS LP, 10% Owner at Staar Surgical (NASDAQ:STAA) executed a significant insider buy, as disclosed in the latest SEC filing. What Happened: In a recent Form 4 filing ...

https://www.tipranks.com/news/the-fly/dentsply-sirona-to-reposition-byte-business-within-aligner-portfolio BTIG lowered the firm’s price target on Staar Surgical ...

LAKE FOREST, Calif., January 13, 2025--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision ...

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision ...

STAAR Surgical has a one year low of $22.40 and a one year high of $52.68. The company has a fifty day moving average of $26.43 and a 200-day moving average of $32.94.

BTIG lowered the firm’s price target on Staar Surgical (STAA) to $39 from $49 and keeps a Buy rating on the shares as part of a broader research note updating the firm’s models on Medical ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...